CORRECTION article

Front. Med., 28 March 2025

Sec. Dermatology

Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1574170

Corrigendum: Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome

This article is a correction to:

  1. Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome

    1. Read original article
Xiaoqing Lang&#x;Xiaoqing Lang1†Ting Wang&#x;Ting Wang2†Shuping GuoShuping Guo1Yao DangYao Dang1Yingjie ZhangYingjie Zhang1Hongye LiuHongye Liu1Hongxia HeHongxia He1Li LiLi Li1Huajie YuanHuajie Yuan1Ting HeTing He1Qiong WangQiong Wang1Shiyu QinShiyu Qin3Runping ChengRunping Cheng1Xingquan YanXingquan Yan1Hongzhou Cui Hongzhou Cui1*
  • 1Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, China
  • 2Department of Dermatology, Shanxi Provincial Integrated Traditional Chinese Medicine and Western Medicine Hospital, Taiyuan, China
  • 3Department of Nursing, Fenyang College of Shanxi Medical University, Fenyang, China

A Corrigendum on
Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome

by Lang, X., Wang, T., Guo, S., Dang, Y., Zhang, Y., Liu, H., He, H., Li, L., Yuan, H., He, T., Wang, Q., Qin, S., Cheng, R., Yan, X., and Cui, H. (2024). Front. Med. 11:1327505. doi: 10.3389/fmed.2024.1327505

In the published article, there was an error in affiliation number 2. Instead of “Department of Dermatology, The Affiliated Hospital of Shanxi University of Traditional Chinese Medicine, Taiyuan, China”, it should be “Department of Dermatology, Shanxi Provincial Integrated Traditional Chinese Medicine and Western Medicine Hospital, Taiyuan, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: novel, frameshift mutation, nevoid basal cell carcinoma syndrome, PTCH1, case report

Citation: Lang X, Wang T, Guo S, Dang Y, Zhang Y, Liu H, He H, Li L, Yuan H, He T, Wang Q, Qin S, Cheng R, Yan X and Cui H (2025) Corrigendum: Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome. Front. Med. 12:1574170. doi: 10.3389/fmed.2025.1574170

Received: 10 February 2025; Accepted: 18 March 2025;
Published: 28 March 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Lang, Wang, Guo, Dang, Zhang, Liu, He, Li, Yuan, He, Wang, Qin, Cheng, Yan and Cui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hongzhou Cui, bWVuanVuY3VpQDE2My5jb20=

†These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.